What is catheter locking during hemodialysis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Catheter Locking During Hemodialysis?

Catheter locking is a procedure performed at the end of each dialysis session where a solution (typically containing an anticoagulant like heparin or citrate) is instilled into each lumen of the central venous catheter and left to dwell until the next dialysis session to maintain catheter patency and prevent infection. 1

Purpose and Mechanism

Catheter lock solutions serve two primary functions:

  • Prevent thrombosis and catheter dysfunction by filling the catheter lumen with anticoagulant solution that prevents blood from clotting within the catheter between dialysis sessions 1, 2
  • Reduce catheter-related bloodstream infections (CRBSI) when antimicrobial agents are added to the lock solution, as these high-concentration solutions can eradicate biofilm-forming bacteria within the catheter lumen 1

Standard Locking Procedure

The technique follows a specific sequence at the end of each dialysis session:

  • Flush each catheter lumen thoroughly with normal saline (5-10 mL) using a turbulent flushing technique to clear residual blood and optimize patency 1, 3
  • Instill the lock solution into each lumen in a volume that matches the internal catheter volume (typically 2-5 mL per lumen) 1
  • Clamp the catheter and leave the solution dwelling until the next dialysis session 1
  • The lock solution is renewed after every dialysis session (typically 3 times per week for most hemodialysis patients) 1

Types of Lock Solutions

Standard Anticoagulant Locks

  • Heparin 1,000 units/mL is the recommended concentration by the American Society of Diagnostic and Interventional Nephrology, balancing catheter patency with lower systemic anticoagulation risk 3, 4, 2
  • Low-concentration citrate (<5%) is an alternative that provides both anticoagulant and antimicrobial properties while minimizing systemic effects 3, 4, 5

Antibiotic Lock Therapy (for Treatment of CRBSI)

When catheter-related bloodstream infection occurs, antibiotic lock therapy becomes a therapeutic intervention rather than prophylaxis:

  • Antibiotic lock must always be combined with systemic antimicrobial therapy, never used alone, with both regimens administered for 10-14 days 1
  • The antibiotic is combined with heparin at supratherapeutic concentrations (100-1000 times the MIC) and instilled into each catheter lumen at the end of each dialysis session 1
  • Success rates vary by pathogen: 87-100% for gram-negative infections, 75-84% for coagulase-negative staphylococci, but only 40-55% for S. aureus 1

Critical Distinctions

Prophylactic locking (routine maintenance) differs fundamentally from therapeutic antibiotic lock therapy (treatment of active infection). The former uses standard anticoagulants to prevent complications, while the latter adds high-concentration antibiotics to treat established CRBSI while attempting catheter salvage 1, 6

Common Pitfalls to Avoid

  • Do not exceed the internal catheter volume when instilling lock solution, as overflow into systemic circulation can cause unintended anticoagulation 4, 2
  • Avoid confusing heparin concentration with total dose: some protocols erroneously use 12,500 units per lumen when they should specify concentration (e.g., 1,000 units/mL) 3
  • For CRBSI due to S. aureus or Candida, catheter removal is recommended rather than attempting salvage with antibiotic lock therapy, unless no alternative catheter site exists 1
  • Antibiotic lock therapy only addresses intraluminal infection and will not eradicate extraluminal or tunnel infections 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Heparin Lock Practices for Hemodialysis Catheters – Evidence‑Based Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Systemic Anticoagulation from Heparin Locks in Dialysis Catheters

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Pros and cons of catheter lock solutions.

Current opinion in nephrology and hypertension, 2013

Related Questions

Can heparin locks for Hemodialysis (HD) catheters enter the systemic circulation?
What is the recommended dose of heparin (unfractionated heparin) in peritoneal dialysis for a patient with fibrin-related issues?
For a blocked anterior central venous catheter, should heparin be used to restore patency or is a thrombolytic agent such as alteplase the preferred first‑line treatment?
For a hemodialysis (HD) patient, is a 12,500‑unit unfractionated heparin lock appropriate for prophylactic catheter line care after treatment, and what volume should be used to fill each lumen?
What is the recommended approach for preventing clotting in dialysis lines?
What is the recommended fluid replacement protocol for a patient with mild diabetic ketoacidosis secondary to type 1 diabetes, including rates, monitoring, and adjustments for adults and children?
How should I manage a type 2 diabetes patient with severe hyperglycemia who is currently on premixed insulin and glipizide but not on metformin?
Is amitriptyline appropriate for a 14‑year‑old patient?
What is the standard treatment regimen for drug‑susceptible (non‑multidrug‑resistant) tuberculosis, including drug selection, dosing, duration, and monitoring?
What is the recommended treatment for a cholangiolar (intra‑hepatic biliary) abscess?
How should I diagnose and manage a patient with left upper quadrant pain, fever, leukocytosis and risk factors such as recent abdominal infection, endocarditis, trauma, immunosuppression, diabetes, or sickle‑cell disease suggestive of a splenic abscess?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.